Health
NHS secures world’s most expensive drug to treat babies with rare muscle disease – The Irish News
Patients will be able to access Zolgensma, a one-time gene therapy, said NHS England.
Up to 80 babies a year born with a rare muscle-wasting disease could receive life-changing treatment after the most expensive drug in the world was licensed for use on the NHS in England.
Infants born with Spinal Muscular Atrophy (SMA), an often fatal condition which affects the spinal cord nerves causing paralysis, will be able to access Zolgensma, a one-time gene therapy, said NHS England.
The drug, which replicates a missing gene and restores nerve and muscle function, has a reported list price…
-
Noosa News23 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General22 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General19 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General12 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore